Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)-Reference-Cited by-同舟云学术

Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902)

Published:2016-04-05 Issue:6 Volume:95 Page:921-929
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Ozaki Shuji,Hata Hiroyuki,Abe Masahiro,Saitoh Takayuki,Hanamura Ichiro,Yano Hiroki,Sunami Kazutaka,Kosugi Hiroshi,Sawamura Morio,Nakazato Tomonori,Masunari Taro,Mori Mayumi,Takagi Toshiyuki,Murakami Hirokazu,Shimizu Kazuyuki

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-016-2661-7.pdf

Reference30 articles.

1. International Myeloma Working Group (2003) Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121(5):749–757

2. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15(12):e538–e548

3. Palumbo A, Bringhen S, Ludwig H, Dimopoulos MA, Blade J, Mateos MV et al (2011) Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood 118(17):4519–4529

4. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T et al (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352(24):2487–2498

5. Richardson PG, Sonneveld P, Schuster M, Irwin D, Stadtmauer E, Facon T et al (2007) Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial. Blood 110(10):3557–3560

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple Myeloma: Current Advances and Future Directions;The Kitakanto Medical Journal;2020-08-01

2. Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline;Journal of Clinical Oncology;2019-05-10

3. A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma;Critical Reviews in Oncology/Hematology;2018-01